510(k) Report

510(k) · Cleared

Cleared

Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)

K213652510(k) TraditionalCleared Jun 28, 2023586-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cresilon, Inc. · QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics

Cleared on Jun 28, 2023 as substantially equivalent to K180152 (Gel-E, Inc., 2018) after a 586-day review. Its family tree reaches back 6 generations to 1997. 1 later device descends from it.

Decided
Jun 28, 2023
Review
586 days
Class
Class U
Product code
QSY
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K972914 (1997). 8 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 6 generations backK972914 Syvek PatchMarine Polymer Technologies, Inc. · 1997
  2. 5 generations backK023298 Hemcon BandageHemcon, Inc. · 2002
  3. 4 generations backK030946 Hemcon Bandage Otc; Hemcon Cath/AidHemcon, Inc. · 2003
  4. 3 generations backK043050 Hemcon Bandage and Hemcon Bandage OtcHemcon, Inc. · 2005
  5. 2 generations backK072486 Modification to Hemcon Bandage and Hemcon Bandage OtcHem Con Medical Technologies, Inc. · 2008 · Recalled
  6. 1 generation backK180152 gel-e FlexGel-E, Inc. · 2018
  7. This deviceK213652 Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc. · 2023
  8. Descendant · cites it directly · 0 of its ownK253609 TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K253609TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K972914Syvek PatchMarine Polymer Technologies, Inc.1997—
−5K023298Hemcon BandageHemcon, Inc.2002—
−4K030946Hemcon Bandage Otc; Hemcon Cath/AidHemcon, Inc.2003—
−3K043050Hemcon Bandage and Hemcon Bandage OtcHemcon, Inc.2005—
−2K072486Modification to Hemcon Bandage and Hemcon Bandage OtcHem Con Medical Technologies, Inc.20086
−1K180152gel-e FlexGel-E, Inc.2018—
0 (this device)K213652Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG)Cresilon, Inc.2023—
+1K253609TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199810
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K213652, 1997–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QSY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QSY device

  1. #1 K240713 Traumagel®score 15.0 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K180152gel-e Flex
Summary page 4
…510(k) Number Gel-E Flex Manufactured by Gel-E, Inc. (Now registered K180152 as Medcura, Inc) 4. Device Description Cresilon Hemostatic Gel™ (CHG™) is a hemostatic gel for external use only,…
Gel-E, Inc.2018—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253609TRAUMAGEL® 2.0 Hemostatic GelCresilon, Inc.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 26 years and passes through 5 companies; a new generation was cleared every 4.9 years on median.
  • 1 of the 8 ancestors has a recall of any class.
  • Of its descendants, K253609 (Cresilon, Inc., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All QSY devices

QSY Hemostatic Wound Dressing Without Thrombin Or Other Biologics: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QSY

2in 2025

2007: 132008: 72009: 92010: 72011: 82012: 72013: 32014: 62015: 62016: 52017: 12018: 52019: 42020: 12021: 12022: 22023: 72024: 42025: 22026 (partial year): 2
2007high 13 (2007) · low 1 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QSY

142in 2024

2007: 63 days median2008: 61 days median2009: 55 days median2010: 75 days median2011: 137 days median2012: 239 days median2013: 161 days median2014: 249 days median2015: 171 days median2016: 161 days median2018: 186 days median2019: 336 days median2023: 586 days median2024: 142 days median
2007high 586 (2023) · low 55 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QSY

No recall names QSY since 2007.

Adverse event reports per year · QSY

14in 2025

2022: 12024: 32025: 14
2007high 14 (2025) · low 0 (2007)2025

MAUDE reports naming product code QSY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007136300
200876100
200995500
201077500
2011813700
2012723900
2013316100
2014624900
2015617100
2016516100
20171—00
2018518600
2019433600
20201—00
20211—00
20222—01
2023758600
2024414203
20252—014
20262—0—

What is it indicated for?

Cresilon Hemostatic Gel™ (CHG™) is a hemostatic gel for external use only.

Cresilon Hemostatic Gel™ (CHG™) is indicated for the local management of bleeding wounds such as minor cuts, minor lacerations, and minor abrasions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213652: Cresilon Hemostatic Gel, CHG, Cresilon Hemostatic Gel (CHG).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213652

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026